I agree, most folks are unaware of the ground-brea
Post# of 72440
We must have some third party sponsorship and/or a deal in order to have the share price reflect a decent representation of the value.
I think DF is planning to do the ovarian P2 trial and will most likely sponsor it. The ASCO presentation was (IMO) notice to the medical community.
Go CTIX!!